Objective-The current data regarding the association between calcium and phosphorus and cardiovascular disease are lacking. The aim of this study was to explore whether dietary calcium and phosphorus intake and their serum levels are associated with the prevalence of coronary artery calcification (CAC) using cardiac computed tomography in asymptomatic participants without a history of chronic kidney disease or cardiovascular disease. Approach and Results-A cross-sectional study was performed in 23 652 Korean participants (40.8±7.3 years, male 83.5%) without chronic kidney disease (estimated glomerular filtration rate≥60 mL/min per 1.73 m 2 ) or clinically overt cardiovascular disease, who underwent cardiac computed tomographic estimation of CAC scores as part of a general health checkup in addition to completing a self-administered food frequency questionnaire. We assessed the relationship of dietary calcium and phosphorus intake and serum levels with CAC scores using both multivariate-adjusted Tobit models and multinomial logistic regression models. Neither dietary calcium nor phosphorus intake was consistently associated with CAC scores. However, the serum calcium, phosphorus, and calcium-phosphorus product levels were significantly associated with the CAC score ratios. In multivariable-adjusted models, the CAC score ratios (95% confidence intervals) comparing the highest quartiles of serum calcium, phosphorus, and calcium-phosphorus product levels to the lowest quartiles were 1.89 (1.36-2.64), 3.33 (2.55-4.35), and 3.98 (3.00-5.28), respectively (P for trend <0.001). Conclusions-Elevated serum levels of calcium, phosphorus, and calcium-phosphorus product, but not dietary consumption, are associated with increased CAC scores. Our findings should be explored in further research. (Arterioscler Thromb The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/In Korean participants (n=23 652) without chronic kidney disease or clinically overt cardiovascular disease, elevated serum levels (even in the normal ranges) of calcium, phosphorus, and calcium-phosphorus product were found to be associated with increased coronary artery calcification using a 64-channel multidetector computed tomography, but dietary consumption did not have this association. The strict control of serum levels of calcium and phosphorus may be needed. Our findings should be explored in further research.
S erum calcium and phosphorus play an essential physiological role in bone mineralization, energy production, membrane transport, signal transduction, and vascular function. 1 Recent experimental and epidemiological studies reported that higher serum calcium or phosphorus level could be associated with the pathogenesis of cardiovascular disease (CVD), including atherosclerosis, 2,3 heart valve calcification, 4,5 vascular calcification, 2, 6 and arterial stiffness. 7, 8 In 2011, a meta-analysis of 47 cohort studies on this issue reported that high serum phosphorus is significantly associated with increased all-cause and cardiovascular mortality. 9 Evidence supporting an association between serum calcium and the risk of death and cardiovascular events is poor among individuals with chronic kidney disease (CKD). In addition, current data on the association between serum calcium and phosphorus and cardiovascular risk remain controversial. 10, 11 Also, even calcium-phosphorus product (CPP) levels may be potentially modifiable risk factors for CVD. 11, 12 Studies of subclinical coronary artery disease can provide an understanding of early-stage coronary artery disease and identify potential risk factors for subclinical coronary artery atherosclerosis. Coronary artery calcification (CAC) scoring using cardiac computed tomography is a commonly used method for detecting and quantifying subclinical calcified coronary plaques, 13 and it can also enable more refined estimation of the future risk of coronary events. 14 Until now, minimal data are available on the association between serum concentration of calcium and phosphorus and the risk of subclinical CVD measured by CAC in a population free of CKD and CVD. 2, 15 Previous studies suggested that higher serum phosphorus levels (even within normal ranges), but not calcium levels, may be a risk factor for coronary artery disease.
Few studies have examined the relationship between dietary intake of calcium and phosphorus and CAC formation. The Framingham cohort study 16 found that total daily calcium intake from the diet and supplements is not associated with increased CAC among 690 women and 588 men over a 4-year follow-up period.
To our knowledge, no study has closely analyzed the association between dietary intake of calcium and phosphorus and serum concentrations and the risk of CAC in an Asian population. Assessing the different effects of dietary intake of these minerals and their serum levels on the risk of coronary artery disease may help in identifying factors contributing to the progression of coronary artery atherosclerosis. In this study, we assessed whether dietary calcium and phosphorus intake and their serum levels are associated with CAC using cardiac computed tomography in asymptomatic participants without a history of CKD and CVD.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
The mean (SD) age and body mass index of the 23 652 participants were 40.8 (7.3) years and 24.3 (3.1) kg/m 2 , respectively. The prevalence of hypertension and diabetes mellitus was 13.8% and 5.3%, respectively. The median (interquartile range) dietary calcium and phosphorus intake per day was 339.3 mg (228.3-481.9) and 759.2 mg (576.8-976.0), respectively. The mean (SD) serum calcium and the median (interquartile range) phosphorus and CPP levels were 9.41 mg/dL (0.31), 3.5 mg/dL (3.2-3.8), and 33.3 mg 2 /dL 2 (30.4-36.1), respectively. Age, alcohol intake, physical activity, family history of CVD, hypertension, diabetes mellitus, dyslipidemia, systolic and diastolic blood pressures, glucose, and homeostasis model assessment of insulin resistance were positively associated with CAC score categories, whereas high education and glomerular filtration rate were inversely associated with CAC score categories (Table 1) . Of the 23 652 subjects, 2523 subjects (10.7%) had CAC score 1 to 100 and 437 subjects (1.8%) had CAC scores >100.
Dietary calcium and phosphorus intake levels were divided into 4 quartiles. In age-, sex-, and multivariate-adjusted Tobit models, neither dietary calcium nor phosphorus intake was associated with CAC score ratios ( Table 2 ). The results from the multinomial logistic regression models were consistent with the Tobit models ( Table 3) .
The serum calcium, phosphorus, and CPP levels were significantly associated with the CAC score ratios. In the multivariable-adjusted Tobit models, CAC score ratios (95% confidence intervals) comparing the highest quartiles of serum calcium, phosphorus, and CPP levels to the lowest quartiles were 1.89 (1.36-2.64), 3.33 (2.55-4.35) , and 3.98 (3.00-5.28), respectively (P for trend <0.001). When serum calcium, phosphorus, and CPP were introduced as continuous variables in the multivariate models, the CAC score ratios (95% confidence intervals) associated with a 1 SD mg increase in serum calcium, phosphorus, and CPP were 1. 30 To explore whether the associations of serum calcium, phosphorus, and CPP levels with the CAC score ratios were influenced by total serum vitamin D levels, a sensitivity analysis adjusting for total serum level of vitamin D was performed among 6148 participants who underwent baseline vitamin D measurements. Additional adjustment for total serum vitamin D levels did not change these results (Table II in the onlineonly Data Supplement). That is, high levels of serum calcium, phosphorus, and CPP were associated with an increased prevalence of CAC regardless of serum vitamin D levels. When we evaluated the relationship of serum calcium and phosphorus levels within the normal range (serum calcium, 8.5-10.5 mg/dL and serum phosphorus, 3.0-4.5 mg/dL) with CAC score ratios, these associations remained (Table III in the onlineonly Data Supplement). The associations of dietary calcium and phosphorus intake and serum calcium, phosphorus, and CPP levels with the CAC score ratios were similar across subgroups of study participants without any significant interactions by age group (<40 versus ≥40 years of age), sex (women versus men), body mass index (<25 versus ≥25 kg/m 2 ), smoking (current smoker versus noncurrent smoker), alcohol intake (<20 versus ≥20 g of alcohol per day), calcium supplements (yes versus no), diabetes mellitus (yes versus no), and hypertension (yes versus no; data not shown).
Discussion
In this large study of 23 652 asymptomatic subjects without overt CVD, we identified 2 major findings. First, dietary calcium and phosphorus intake was not associated with the prevalence of subclinical coronary artery disease. Second, high levels of serum calcium, phosphorus, and CPP were associated with an increased prevalence of CAC, specifically CAC scores>100 as a robust marker of coronary atherosclerotic burden and a predictor of future CVD events. Adjustment for traditional CVD risk factors and subgroup analyses did not substantially change these associations. The majority of the epidemiological data examining the association between serum calcium, phosphorus, or CPP level and the risk of CAC have come from populations with advanced CKD. [17] [18] [19] Evidence of serum calcium and phosphorus levels affecting subclinical CAC in populations with normal kidney function is limited. 2, 6, 15 The latest notable observational study of 7553 participants with near-normal kidney function 6 reported that elevated serum levels of calcium, phosphorus, and CPP were independent risk factors for calcified coronary atherosclerotic plaques as assessed by cardiac computed tomographic angiography. This relationship is thought to contribute to vascular calcification, not to the formation of noncalcified plaques. Nevertheless, that study had substantial limitations in that authors did not consider nutritional information such as dietary calcium and phosphorus intake, which is likely an important confounding factor. In addition, the participant characteristics in that study were heterogeneous because the study cohort included asymptomatic individuals who underwent a general health examination, potential patients with abnormal resting or stress electrocardiographic tests or cardiac symptoms, and patients with pre-existing peripheral vascular disease or stroke. Furthermore, although drug treatment for patients with CVD or stroke, such as antiplatelet or anticoagulant agents, could suppress or alter the progression of vascular atherosclerosis, participant medication records BMI indicates body mass index; BP, blood pressure; CAC, coronary artery calcification; CVD, cardiovascular disease; GFR, glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; HEPA, health-enhancing physical activity; hsCRP, high-sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment of insulin resistance; and LDL-C, low-density lipoprotein cholesterol.
Data are *means (SD), ‡medians (interquartile range), or percentages. †More than or equal to 20 g of ethanol per day.
were not considered. Therefore, it is possible that their results were affected by residual confounders. By contrast, we were able to verify the effects of serum calcium, phosphorus, and CPP levels on the risk of CAC in an asymptomatic population without any history of CKD and CVD in the present study. Although a full understanding of these findings has yet to be reached, several studies have suggested a positive association between serum calcium and phosphorus levels and the risk of vascular calcification by a highly regulated, active process similar to osteogenesis. 1, 20 This phenomenon includes boneforming phenotypic alterations of vascular smooth muscle cells, mainly arising from an imbalance between promoters such as Ca-P product and inhibitors of mineral deposition. 20 Too much calcium in the serum might modify regulators of Table 3 CAC indicates coronary artery calcification; CI, confidence interval; and PR, prevalence ratio. *Estimated from multinomial logistic regression models using CAC scores as outcomes categorized as 0, 1-100, and >100. The multivariable model was adjusted for age, sex, smoking status, alcohol intake, physical activity, body mass index, educational level, family history of cardiovascular disease, medication for dyslipidemia, history of diabetes mellitus, history of hypertension, and total calorie intake. calcification, such as pyrophosphate, fetuin-A, osteocalcin, and matrix Gla protein, or directly bind to the calcium-sensing receptor on the cells of the vessel wall. 1, 21 Low levels of calcium-sensing receptor immunoreactivity were detected in atherosclerotic, calcified arteries in vivo and in vitro. 22 Matrix Gla protein knockout mice developed extensive aortic calcification and died prematurely of aortic rupture in an experimental study. 23 Also, cell death or production of calcifying matrix vesicles from vascular smooth muscle cells are other risk factors reported as stimulated by high calcium or phosphorous. [24] [25] [26] Likewise, elevated phosphorus levels can cause vascular disease by evoking atherosclerosis, increased vessel wall thickness, arterial stiffness, and vascular calcification. 2, 6, 27 Disturbances of the axis involving fibroblast growth factor-23 as an important regulator of serum phosphorus level in the body and its coreceptor, Klotho, may have direct effects on the vasculature, leading to calcification in patients with CKD. 27, 28 Other plausible mechanisms linking high phosphorus levels to vascular disease could include inhibition of 1,25-dihydroxyvitamin D synthesis and increased production of parathyroid hormone. 11, 29 Lower levels of vitamin D could increase vascular calcification and elevated parathyroid hormone may induce production of interleukin-6, which has a key role in bone formation and probably vascular calcification as well. 30, 31 The results of the present study did not change when analyses were confined to participants with serum calcium and phosphorus in the normal ranges. Moreover, there was no significant difference in the results when we adjusted serum calcium for albumin level using the following formula: corrected serum calcium=total calcium+(0.8 x [4.5-serum albumin]). That is, even relatively higher levels of serum calcium and phosphorus within the normal ranges might be involved in pathological vascular calcification among healthy individuals, which supports the need for adjusted normal ranges. However, a clear mechanism for these observations has yet to be substantiated.
. Prevalence Ratios* (95% CI) of Coronary Artery Calcification by Dietary Calcium and Phosphorus Intake With Coronary Artery Calcification in 23 652 Health Checkup Examinees at Kangbuk Samsung Hospital in 2011 to 2013
As shown in previous studies for CVD risk, [32] [33] [34] we also found that dietary consumption of calcium and phosphorus was irrelevant to the prevalence of CAC. This finding may have a few plausible reasons. First, serum calcium and phosphorus are necessarily regulated within the narrow normal ranges under tight homeostatic control by the calciotropic hormones such as parathyroid hormone, calcitonin, and vitamin D in healthy individuals. 1 Our data showed that dietary intake of these minerals did not relate to their respective serum levels. 34 Second, a majority of participants consumed calcium from only food, not from both food and supplements (0.7%) in this study. Supplemental calcium intake is known to rapidly increase blood concentration within 2 hours and could affect the secretion of calciotropic hormones and bone reabsorption. By contrast, calcium from foods, typically consumed during a mixed meal, would be absorbed slowly over several hours and have a much smaller effect than supplements on blood concentration and metabolic response. 35 Third, atherosclerotic calcification in vessels may require a long-standing pathological process, including lipid accumulation, endothelial injury, myocyte infiltration, and extracellular matrix synthesis. 36 Thus, the dietary data collected at one time point in this study may not have reflected the current state of vascular disease, even though the questionnaire asked about eating habits over the past year. Fourth, the relatively low calcium and phosphorus intake among study participants did not have a noticeable influence on vascular disease. The 2010 Korean Nutrition Society recommended a daily calcium intake of 700 to 750 mg for men >19 years old and 650 to 700 mg for women >19 years old, except for pregnant or lactating women. 37 The US Institute of Medicine recently recommended a calcium intake of 1000 mg/d for all adults aged 19 through 70, except for women >51 years old. 38 However, the mean estimation of calcium intake was at best 356.4 mg/d for men and 455.3 mg/d for women in this study; that is, less than half the recommended amount. As for phosphorus intake, the 2010 Korean Nutrition Society recommends an intake of 700 mg for both men and women >19 years old. 37 Similarly, the mean consumption of daily phosphorus was 810.4 mg/d for men and 848.5 mg/d for women in the present study. However, these values were still less than half of the 1766 mg/d reported in a previous Western study. 2 These variations in dietary habits between countries may be responsible for some of the discrepancies found between our findings and the observational studies that reported a high dietary calcium intake is associated with an increased risk of CVD among Western populations. 39, 40 The present study has several limitations. First, we had no data on serum concentrations of parathyroid hormone as a key regulator of both calcium and phosphorus metabolism. Instead, we excluded individuals with estimated glomerular filtration rate<60 mL/min per 1.73 m 2 at baseline and adjusted for estimated glomerular filtration rate in multivariate models so as to control for secondary hyperparathyroidism. Second, because of the cross-sectional study design, it was not possible to demonstrate causal relationships between dietary intake and serum levels and the risk of CAC. Long-term prospective studies are required for this purpose. Third, as mentioned before, we were unable to investigate the association between supplementary calcium intake and the risk of vascular calcification because only a small percentage of participants reported using supplements (0.7%). Finally, this study has an inevitable limitation in that the CAC does not always predict the future risks of individualized cardiovascular events.
Nevertheless, to our knowledge, this is the first study examining the correlation between dietary intake of calcium and phosphorus and the risk of subclinical CAC that used a large sample of nearly 24 000 healthy Asian individuals without overt CVD or CKD. Previous related studies were performed in Western countries or only focused on serum levels, while we investigated detailed nutritional information using a validated questionnaire.
In conclusion, in a large sample of 23 652 Korean participants free of CKD and CVD, elevated serum levels of calcium, phosphorus, and CPP, but not dietary consumption, were associated with increased CAC.
